Aim: The aim of the present study was to evaluate and compare the effects of a new antipsychotic, aripiprazole (unique due to its mechanism of action), with the effects of selected antipsychotic drugs, such as quetiapine, olanzapine, clozapine, risperidone, and ziprasidone (at the final concentrations corresponding to clinically effective doses used for the treatment of acute episodes of schizophrenia) on lipid peroxidation in human plasma measured by the level of thiobarbituric acid reactive substances (TBARS), which is a marker of oxidative stress.
Results: Our results indicate that antipsychotics at doses recommended for the treatment of acute episodes of schizophrenia may induce distinct changes in the levels of lipid peroxidation products (TBARS) in plasma. Aripiprazole had no effect on the level of a lipid peroxidation marker in plasma, although used at lower doses it showed insignificant prooxidative properties similar to clozapine. Quetiapine had the strongest antioxidant properties, contrary to prooxidative action of risperidone, ziprasidone or haloperidol, and clozapine at lower doses. Olanzapine reduced the level of TBARS in plasma only at a lower dose.
Conclusion: Antipsychotics at doses recommended for the treatment of acute episode in schizophrenia may induce the distinct changes in plasma lipid peroxidation. Aripiprazole did not induce significant changes in plasma lipid peroxidation. In further studies, the role of oxidative stress in schizophrenic patients together with their clinical symptomatology and use of antipsychotics should be taken into account.
Key words: antipsychotics, lipid peroxidation, oxidative stress, pro-/antioxidant properties, schizophrenia. O XIDATIVE STRESS LEADING to oxidative changes in different biomolecules may be involved in the pathology of schizophrenia. 1 Peroxidation of polyunsaturated fatty acids caused by oxidative stress plays an important role in etiopathogenic mechanisms of this illness. 2, 3 Evidence supporting this view includes the increased level of lipid peroxidation in experimental studies on animal models. [4] [5] [6] Oxidative injury in schizophrenia may be caused partly by lipid peroxidation in plasma and cerebrospinal fluid of patients and by altered protection against free radicals caused by the changed levels of both enzymatic and nonenzymatic antioxidants in chronic, naïve, and firstepisode patients. 1, 5 Studies on animals have shown that administration of antipsychotics, especially typical antipsychotic drugs, may lead to an increased production of free radicals by blocking dopamine D2 receptors and increased turnover of dopamine. Antipsychotic drugs have been grouped according to both the pattern of clinical action and mechanisms of action. Antipsychotic drugs, such as haloperidol, have been called typical or first-generation medications. Second-generation or atypical antipsychotic drugs (AAD), such as olanzapine, risperidone, clozapine, ziprasidone, and quetiapine, are high-affinity D 2 and 5HT 2A receptor antagonists.
There is one drug, aripiprazole, which is suggested as third-generation. This antipsychotic is unique due to its mechanism of action. From the pharmacological point of view, it presents a new mechanism of action, in which partial agonist activity at D 2 , D 3 , and 5-HT 1A receptors is connected with antagonist activity at 5-HT 2A receptors. Aripiprazole is the first partial dopamine agonist that has been accepted as an antipsychotic drug for clinical use. Moreover, it is regarded as a dopamine-serotonin system stabilizer due to its activity at the 5-HT 2A and 5-HT 1A receptors. 7 Antipsychotics may induce membrane lipid peroxidation and changes in the level of antioxidant enzymes in the brain. 8 Parikh et al. 6 have presented evidence for increased lipid peroxidation and reduced superoxide dismutase activity in the brain of rats chronically treated with haloperidol, but they showed no changes in the activities of antioxidant enzymes and lipid peroxidation products in the brain of rats that received atypical antipsychotics, such as risperidone, olanzapine, or clozapine. Effects of antipsychotic drugs observed in vitro may also occur in vivo. Several studies have shown that haloperidol exerts prooxidative effects in patients with schizophrenia treated with this drug.
9-11 Kropp et al. 10 revealed that the concentration of malondialdehyde (MDA; a marker of lipid peroxidation) after 3 weeks of pharmacotherapy was significantly higher in the group treated with haloperidol than in that treated with other AAD (clozapine, risperidone, quetiapine). There is still the unresolved question as to how these AAD influence oxidative stress and lipid peroxidation. Several studies have demonstrated that some of the AAD have no effect on lipid peroxidation and do not alter the activity of antioxidant enzymes. 1, 6 In other studies, changes in activity of superoxide dismutase in patients with schizophrenia during treatment with risperidone were found. 11 Treatment with antipsychotics may affect lipid metabolism and may lead to other toxic effects associated with the generation of reactive oxygen species (ROS). 12 Pai et al. 5 demonstrated that oxidative stress with the production of ROS is involved in the toxic effects exerted by haloperidol and causes a sequence of cellular changes, which may lead to apoptosis. It seems that typical antipsychotic drugs operate mostly as prooxidants, contrary to the AAD that may reduce lipid peroxidation and have antioxidant activity. 10, 13 Aripiprazole is a relatively new drug with the unique mechanism of action and widespread clinical application. It possesses considerable efficacy in psychosis treatment, comparable to other AAD, and is beneficial in treating affective, cognitive, and negative symptoms of schizophrenia.
14 Its effect on oxidative changes in schizophrenia is unknown. As antipsychotics used in the treatment of schizophrenia may have different effects on oxidative stress, the aim of the present study was to evaluate the effect of aripiprazole and compare it with the action of other selected AAD (quetiapine, olanzapine, clozapine, risperidone, ziprasidone) and a typical antipsychotic, haloperidol, on lipid peroxidation in plasma derived from healthy subjects and measured by the level of thiobarbituric acid reactive substances (TBARS).
METHODS

Subjects
Seventy healthy volunteers with normal body mass indexes and not treated with drugs were recruited from students of the Medical University of Lodz and matched for age (24-26 years) without psychiatric, neurological, or somatic disorders or history of head injuries, as well as lipid or carbohydrate metabolism disorders. The current mental status of each student was assessed by clinical psychiatrists (Department of Biological Psychiatry, Medical University of Lodz). The psychiatric examination of subjects was performed using the Mini International Neuropsychiatric Interview. 15 Subjects with medical illnesses were excluded from the study. Healthy subjects did not smoke or use any other addictive substances or antioxidant supplementation; their diet was balanced (meat and vegetables).
All subjects signed an informed consent form for participation in the study according to the protocol approved by the Committee for Research on Human Subjects of the Medical University of Lodz (number RNN/899/2000). Tests were performed at the Laboratory of the Department of Biological Psychiatry, Medical University of Lodz.
Isolation of plasma
Blood from 70 healthy subjects was collected into citric acid/citrate/dextrose solution (5:1 v/v) between 08.00 and 08.30 hours and centrifuged for 20 min at 573 g 20 C in a Sigma 3K30 centrifuge to obtain plasma. All basic reagents and the active substances of atypical drugs were obtained from Sigma-Aldrich (St. Louis, MO, USA) and haloperidol from PolfaWarsaw (Warsaw, Poland). All other reagents were of analytical grade and were provided by commercial suppliers. The studied drugs in the form of active ingredients were dissolved in 0.01% dimethyl sulfoxide (DMSO, Sigma-Aldrich). Drug solutions in DMSO were added to 0.5 mL of plasma to obtain the final concentrations of the drug corresponding to its concentrations in plasma of patients treated with this drug. The final concentrations of the antipsychotic in plasma corresponded to doses clinically effective for treatment of acute episodes of schizophrenia. We used lower and higher concentrations: quetiapine, 250 and 387 ng/mL; olanzapine, 23 and 45 ng/mL; clozapine, 370 and 450 ng/mL; aripiprazole, 163 and 242 ng/mL; risperidone, 45 and 65 ng/mL; ziprasidone, 140 and 260 ng/mL; and haloperidol, 10 and 20 ng/mL. The controls were plasma samples without drug and plasma with drug at 0 time. Samples of plasma with antipsychotics and controls were incubated for 24 h at 37 C. After 24 h incubation, the levels of TBARS were measured.
The incubation was stopped by cooling the samples in an ice bath.
Evaluation of lipid peroxidation level
Samples of plasma were transferred to an equal volume of 20% (v/v) cold trichloroacetic acid in 0.6 M HCl, mixed and centrifuged at 1200 g for 15 min. To one volume of clear supernatant, 0.2 volume of 0.12 M thiobarbituric acid in 0.26 M Tris, pH 7.0 was added, and immersed in a boiling water bath for 15 min. In control plasma and in samples of plasma with the drug, after the incubation, the concentrations of TBARS were measured spectrophotometrically, according to the modification of the Rice-Evans method. 16, 17 The absorbance was measured in a SEMCO spectrophotometer at 535 nm in 1-cm cuvettes. The TBARS concentrations expressed in μmol/L were calculated based on the absorbance value, using the molar extinction coefficient for
). All estimations were performed twice, including control plasma samples, in which spontaneous lipid peroxidation occurred, without the influence of the drug.
Statistical analysis
All the values in this study were expressed as the mean AE standard error of the mean. In order to eliminate outliers, Grubbs' test was performed. The data were analyzed with multifactorial variance analysis (two-way analysis of variance [ANOVA] test). Post hoc comparisons for the TBARS levels were carried out with Fisher's least significant difference (LSD) test. STATISTICA v.10 by StatSoft (Palo Alto, CA, USA) was used.
RESULTS
Our comparative study in vitro has shown that the selected atypical antipsychotic drugs (aripiprazole, quetiapine, olanzapine, clozapine, risperidone, ziprasidone) and haloperidol at the final concentrations corresponding to their clinically effective doses in patients' plasma after the treatment of acute episode of schizophrenia [18] [19] [20] differ in their ability to affect lipid peroxidation in human plasma expressed as the TBARS level (Figs 1-3) . The effects of treatment with two doses (lower and higher) of the studied drugs on the TBARS level were measured. Aripiprazole did not distinctly change the level of the measured marker of the oxidative stress in plasma. Its effect was dependent on the used dose. At a lower dose, aripiprazole induced insignificant lipid peroxidation in plasma, indicating prooxidative properties (Figs 1,2a) , whereas aripiprazole at a higher concentration, like clozapine, had an insignificant antioxidative effect on the TBARS level in plasma (Figs 1,2b) . Clozapine only at a lower dose showed prooxidative properties (Figs 1,2a) . Quetiapine and olanzapine, especially at lower doses, reduced the level of TBARS in comparison with the control by about 14% and 7%, respectively (Fig. 1 ).
Clozapine at a higher dose showed reducing properties. Risperidone, ziprasidone, and haloperidol, especially at higher concentrations, had oxidative properties and caused an increase in the TBARS level in human plasma by about 13%, 28%, and 14%, respectively (Fig. 1) . The analysis of ANOVA II test revealed that the differences in the TBARS levels significantly depended on the studied drug (P = 3.78 × 10 −7 ). In the post hoc analysis (LSD test), significant differences in the TBARS level between the investigated AAD were found (Fig. 2,  Tables 1 and 2 ). The comparison between the action of aripiprazole and other antipsychotic drugs at their lower and higher concentrations on lipid peroxidation in human plasma is presented in Figure 3 . Our results confirmed that atypical antipsychotic drugs have different effects on plasma lipid peroxidation. Aripiprazole induced insignificant changes in lipid peroxidation. Among the tested antipsychotics, the strongest prooxidative effect was shown by ziprasidone, which was stronger than that of risperidone or haloperidol (Fig. 1) . Quetiapine presented the highest antioxidant activity reducing the level of TBARS in plasma by about 15% at a lower concentration. Olanzapine was less active in reducing lipid peroxidation than quetiapine (Figs 1,2) .
DISCUSSION
Schizophrenia is one of the most severe and chronic forms of mental disorders. Its etiopathogenesis has not yet been clarified. Effective treatment of this illness still remains a challenge for psychiatrists. It is well known that oxidative stress with a lower Common markers used to assess the extent of oxidative stress in schizophrenic patients are the products of oxidized biomolecules -lipids, proteins, and nucleic acids -and also the activities of the antioxidant defense system. 21 Lipid peroxidation of unsaturated fatty acids is commonly measured and may be expressed as TBARS or MDA, 4-hydroxynonenal, and isoprostanes. We used the spectrophotometric method for the estimation of lipid peroxidation products based on the reaction of unsaturated fatty acid products, mainly aldehydes, with thiobarbituric acid, and expressed the results as TBARS (Figs 1-3) . Most of the published data concerning the oxidative stress and oxidative damage to lipids in schizophrenia are based on this estimation in plasma. 22 The contribution of oxidative injury to the pathophysiology of schizophrenia has been indicated by the increase in lipid peroxidation products in plasma and cerebrospinal fluid of patients, with the altered levels of both enzymatic and nonenzymatic antioxidants in chronic, naïve, and firstepisode patients. [23] [24] [25] [26] [27] [28] There is controversy regarding the oxidative stress status in patients with schizophrenia and other psychiatric disorders treated with antipsychotic drugs. Antipsychotic drugs improve symptoms but with different levels of side-effects, such as inducing or reducing oxidative stress. The use of an adequate antipsychotic drug in schizophrenia is important. The question of which antipsychotic drug should be preferred for the treatment of schizophrenia is controversial and major side-effects of AAD should be taken into account. Antipsychotics differ substantially in side-effects and efficacy. Our study focused on the pro-and antioxidative effects of the tested drugs. TBARS or the end products of lipid peroxidation, such as MDA, are widely used markers of oxidative stress in clinical studies. We used the method of TBARS estimation to establish the changes in lipid peroxidation after incubation of plasma with the selected antipsychotic drugs. ROS react with all classes of biomolecules, including lipids, especially with unsaturated acids. Free-radical-induced lipid peroxidation is a chain reaction leading to aldehyde products, such as MDA, 4-HNE, and others. Determination of MDA level (in reaction with thiobarbituric acid [TBA] ) is one of the most frequently used methods in free-radical research; 9, 11, 12, [29] [30] [31] however, this reaction is fairly nonspecific as many substances, including sugars and others, react with TBA, forming chromogen identical to a product of the reaction. 21 In our study, the changes in the level of MDA derived from plasma lipids were expressed as TBARS. The present results confirmed and provided additional evidence that the tested AAD at the final concentrations corresponding to clinically effective doses used for treatment of schizophrenia (acute episode) may change, inducing or reducing lipid peroxidation after incubation of plasma with drugs (Figs 1-3) . For the first time, we have shown that aripiprazole, which may be considered as a thirdgeneration antipsychotic drug, does not cause in vitro distinct oxidation of lipids in plasma. In a lower clinically effective dose, an insignificant increase in TBARS was observed, similar to that obtained after the incubation of clozapine. The action of aripiprazole on the level of TBARS was similar to the clozapine effect. We have confirmed that haloperidol increases lipid peroxidation and has prooxidative properties. Among the tested antipsychotics, ziprasidone shows the strongest prooxidative activity. On the contrary, quetiapine reduced the level of TBARS demonstrating antioxidant properties and it seems that quetiapine protecting against lipid peroxidation may be the most active antioxidant among the tested antipsychotic drugs. Oxygen may also exert toxic effects due to formation of oxygen free radicals and other ROS, which include both free oxygen radicals and species that are not free radicals (hydrogen peroxide, singlet oxygen, ozone, hypochlorite, and peroxynitrite). They can react with all classes of biomolecules, including lipids, in plasma. Our comparative study showed that quetiapine revealed the strongest antioxidant effect in plasma. It indicates that defense mechanism of quetiapine against oxidative stress contributes to its protective effects against the peroxidation of plasma components. Quetiapine has unique therapeutic effects in schizophrenia and some results suggest that quetiapine may function as a scavenger of ROS by capturing hydroxyl radicals *OH, which are formed in Fenton reaction (formation *OH from H 2 O 2 ). 32 Hydroxyl radical is the most reactive oxidant in the living system. We suggest that quetiapine, by eliminating *OH radicals, attenuates oxidative stress, thus protecting brain cells against oxidative stress damage. Our results suggest that the tested AAD exhibit pro-and antioxidant properties that may contribute to their therapeutic action in psychiatric disorders, and may be involved in oxidative stress observed in schizophrenia. 12, 23, 33 The studied AAD differ in their ability to affect lipid peroxidation in plasma of healthy individuals (Figs 1-3 ) but it is not clear whether AAD may induce oxidative damage in the brain. It seems that the white matter with a substantial lipid content may be the region highly sensitive to lipid peroxidation. Other tissues and organs, such as the blood and liver, may also be affected by AAD. 30 The results of Andreazza et al. 30 suggest that haloperidol and clozapine may induce oxidative stress in the brain and liver of rats, but do not produce significant changes in serum. 30 Available data on the role of AAD on free radical metabolism and oxidative stress remain controversial. 7, 31, 32, [34] [35] [36] The results of our earlier study using several tests in cell line (mouse neuroblastoma Neuro 2a cells) 33 and the findings of Brinholi et al. 37 in an in vitro model showed that antipsychotics, such as clozapine and olanzapine, Reinke et al. 34 reported that haloperidol and clozapine, but not olanzapine, induced oxidative stress in the rat brain. Padurariu et al. 31 presented lipid peroxidation (expressed as MDA) in schizophrenic patients treated with haloperidol (1-2 mg/daily dose), olanzapine (20 mg/daily dose), quetiapine (300 mg daily/ dose), and risperidone (2-4 mg/daily dose). They found a significant increase in the level of MDA in serum of schizophrenic patients compared to control subjects. Recently, antioxidant effects of risperidone (by lowering lipid peroxidation, and increasing the antioxidant defense against this process related to paraoxonase 1) in drug-naïve firstepisode schizophrenic patients have been described by Noto et al. 39 Increasing knowledge on the impact of AAD redox can contribute significantly to the progress in the field of biochemistry of oxidative stress, psychiatry, and psychopharmacology. We aimed to create hierarchies of the comparative pro-and antioxidative properties of the tested antipsychotics in vitro by means of the oxidative stress marker estimation. The results of our study clearly demonstrate that antipsychotic drugs may exhibit antioxidant as well as oxidant activities. For the first time, we have shown that aripiprazole with the unique mechanism of action does not induce significant changes in lipid peroxidation. Our results suggest that atypical antipsychotic drugs may at least partially normalize ROS metabolism and oxidative stress in psychiatric disorders. Further studies are necessary to elucidate oxidative stress in schizophrenic patients after treatment with antipsychotic drugs.
